SFRP2 expression also seems to be involved in tumor aggressiveness and invasiveness, indicated by the largest SFRP2 downregulation in aggressive [66] and invasive [61] pituitary adenoma compared to their less aggressive or invasive tumor types, respectively. Here, SFRP2 is linked to neoplasm.